Chemoinformaics analysis of 31-Nor-Lanosterol
Molecular Weight | 412.702 | nRot | 4 |
Heavy Atom Molecular Weight | 364.318 | nRig | 21 |
Exact Molecular Weight | 412.371 | nRing | 4 |
Solubility: LogS | -6.608 | nHRing | 0 |
Solubility: LogP | 7.417 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 81.2381 |
nHD | 1 | BPOL | 48.1539 |
QED | 0.462 |
Synth | 4.69 |
Natural Product Likeliness | 3.387 |
NR-PPAR-gamma | 0.054 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.749 |
Pgp-sub | 0 |
HIA | 0.006 |
CACO-2 | -4.8 |
MDCK | 0.00000853 |
BBB | 0.132 |
PPB | 0.963941 |
VDSS | 4.312 |
FU | 0.0129398 |
CYP1A2-inh | 0.047 |
CYP1A2-sub | 0.527 |
CYP2c19-inh | 0.061 |
CYP2c19-sub | 0.974 |
CYP2c9-inh | 0.116 |
CYP2c9-sub | 0.534 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.624 |
CYP3a4-inh | 0.373 |
CYP3a4-sub | 0.863 |
CL | 20.482 |
T12 | 0.008 |
hERG | 0.055 |
Ames | 0.034 |
ROA | 0.055 |
SkinSen | 0.249 |
Carcinogencity | 0.041 |
EI | 0.013 |
Respiratory | 0.611 |
NR-Aromatase | 0.286 |
Antiviral | No |
Prediction | 0.699492 |